In all tested lymphoma lines, drug treatment led to increases of the proapoptotic proteins (Bim, Bad, and PUMA) and downregulation of the antiapoptotic proteins (BCL-XL and MCL-1) (Figure 9). Here, MCL1 is linked to lymphoma.